Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Awad

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Environmental Science and Pollution Research International|August 14, 2017
PCB dechlorination hotspots and reductive dehalogenase genes in sediments from a contaminated wastewater lagoonTimothy E Mattes, Jessica M Ewald, Yi Liang, et al.
Experimental Dermatology|January 7, 2026
Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?Andrew Awad, Yong Chern Kho, Leila Asfour, et al.
Allergy|August 4, 2022
Safety of COVID-19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi-centre cohort studyJoseph F De Luca, Andrew Awad, Sara Vogrin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2023
Delayed cutaneous hypersensitivities to COVID-19 vaccination: Phenotypic distribution and tolerability of vaccine rechallengeJoseph F De Luca, Andrew Awad, Sara Vogrin, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Blister fluid as a cellular input for <i>ex vivo</i> diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesisAndrew Awad, Effie Mouhtouris, Catriona Vi Nguyen-Robertson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 1, 2023
Durability of immune responses after drug reaction with eosinophilia and systemic symptomsAndrew Awad, Effie Mouhtouris, Allison Clatch, et al.
JAMA Internal Medicine|July 17, 2023
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical TrialAna Maria Copaescu, Sara Vogrin, Fiona James, et al.
BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Environmental Science and Pollution Research International|August 14, 2017
PCB dechlorination hotspots and reductive dehalogenase genes in sediments from a contaminated wastewater lagoonTimothy E Mattes, Jessica M Ewald, Yi Liang, et al.
Experimental Dermatology|January 7, 2026
Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?Andrew Awad, Yong Chern Kho, Leila Asfour, et al.
Allergy|August 4, 2022
Safety of COVID-19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi-centre cohort studyJoseph F De Luca, Andrew Awad, Sara Vogrin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2023
Delayed cutaneous hypersensitivities to COVID-19 vaccination: Phenotypic distribution and tolerability of vaccine rechallengeJoseph F De Luca, Andrew Awad, Sara Vogrin, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Blister fluid as a cellular input for <i>ex vivo</i> diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesisAndrew Awad, Effie Mouhtouris, Catriona Vi Nguyen-Robertson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 1, 2023
Durability of immune responses after drug reaction with eosinophilia and systemic symptomsAndrew Awad, Effie Mouhtouris, Allison Clatch, et al.
JAMA Internal Medicine|July 17, 2023
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical TrialAna Maria Copaescu, Sara Vogrin, Fiona James, et al.
BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.
Pageof 3